City of Hope
1500 E Duarte Rd
About City of Hope
City of Hope, an innovative biomedical research, treatment and educational institution with over 5,000 employees, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate, patient-centered philosophy.
Founded in 1913 and headquartered in Duarte, California, City of Hope is a remarkable non-profit institution, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network, an alliance of the nation’s 20 leading cancer centers that develops and institutes standards of care for cancer treatment.
Individually we are many things. Together, we are hope.
27 articles with City of Hope
In people with diabetes, periods of high blood sugar can negatively impact their health years later, even if they get their blood sugar under control. While this ‘metabolic memory’ phenomenon has been known for years, why it happens is poorly understood.
City of Hope’s Triplex Vaccine Reduces Rate of CMV Complications in Transplant Recipients by 50 Percent and Spurs Immunity Against the Virus
Results from a phase 2 randomized trial study published today in Annals of Internal Medicine
World-Renowned Cancer Experts Are Speeding Lifesaving Cancer Research and Treatments to Newport Beach and the Region
Research Led by City of Hope’s Bart O. Roep, Ph.D., Advances Personalized Medicine for Children With Type 1 Diabetes
Novel ways to classify patients for better treatment outcomes published in Diabetologia and Diabetes Care
This modified design for the CRISPR gene editing tool could eventually improve therapies for HIV and sickle cell disease
City of Hope, San Antonio Regional Hospital Host Grand Opening for New City of Hope Cancer Center in Inland Empire
The opening shortens the commute for residents of Upland and of most nearby cities who are seeking leading-edge oncology treatment
City of Hope Researchers Receive Large US Department of Defense Grant to Study Imugene Oncolytic Virotherapy CF33 in Gastric Cancer
Imugene Limited announced that prominent City of Hope researchers Yanghee Woo, MD, Associate Clinical Professor, Department of Surgery and Director, Gastroenterology Minimally Invasive Therapy Program, together with Yuman Fong, MD, Professor and Chair of the Department of Surgery, received a AU$564,173 US Department of Defense Grant
Betty Ferrell, director of the Division of Nursing Research and Education at City of Hope, elected to esteemed National Academy of Medicine
Membership into this academy is one of the highest honors in health and medicine
Harlan Levine, M.D., president of strategy and business ventures at City of Hope, joins the governing board of the bioscience ecosystem catalyst, BioLA
Mustang Bio Announces City of Hope Receives $4.1 Million in Grant Awards for Recently Opened First-of-Its-Kind Clinical Trial for Patients with Recurrent Malignant Glioma
Mustang Bio, Inc. congratulated City of Hope, a world-renowned independent cancer research and treatment center, on its receipt of $4.1 million in grant awards for a clinical trial of MB-101 in combination with nivolumab and ipilimumab in patients with recurrent malignant glioma.
The trial, which received a $4.1 million in grants from the National Institutes of Health and Gateway for Cancer Research, combines City of Hope’s unique CAR T cell therapy with immune checkpoint inhibitors
Luminaries from industry, healthcare and academia are converging at the Leadership in the Age of Personalization® Executive Summit, on October 9, 2019 in Huntington Beach, California, presented by GLLG.
This combination targeted therapy may offer hope to infants diagnosed with a deadly type of leukemia
With its long-standing commitment to patients, the designation makes City of Hope the highest ranked cancer hospital in the West
City of Hope Study Finds a Novel Mechanism of Action for Natural Killer Cells in Checkpoint Inhibitor Therapy for Cancer
PD-L1+ NK cells may prove to be another important immune effector cell for checkpoint inhibitor-based cancer immunotherapy
City of Hope announced that its Northern California Real Estate & Construction Council will present its highest honor – the 32nd annual Spirit of Life® Award – to Jeff Hoopes, chairman of Swinerton and one of the most respected and successful executives in the construction industry.
City of Hope Reveals Its Bold Vision to Invest More Than $1B for World-Class Cancer Care at FivePoint Gateway in Orange County
Recognizing immediate need, City of Hope accelerates plans to bring highly specialized cancer care, phase I-III clinical trials, and precision medicine and early detection to the nation’s sixth most populous county
City of Hope Harmonizes Research, Medical Care to Create Melody That Breathes New Life into Cancer, Diabetes Patients
Seven patients, accompanied by reality TV star Ethan Zohn, share their stories about how City of Hope’s compassionate care and innovative treatments composed a new melody of life for them.
City of Hope Doctors Present New Research on CAR T Cell Therapy, Bone Marrow Transplants and Other Treatments for Blood Cancers
Data will be presented at American Society of Hematology Annual Meeting Dec. 1-4
City of Hope | South Bay Opens Today in the New $80 Million Providence Advanced Care Center in Torrance
One of the nation’s premier cancer centers now offers multidisciplinary cancer care in the region